Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Tianwen Yin"'
Publikováno v:
Thoracic Cancer, Vol 15, Iss 9, Pp 738-748 (2024)
Abstract Background Brain metastases (BMs) are common in small cell lung cancer (SCLC), and the efficacy of immune checkpoint inhibitors (ICIs) in these patients is uncertain. In this study we aimed to develop and validate a radiomics nomogram based
Externí odkaz:
https://doaj.org/article/d248a89afc984827bed6d853d012145f
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTThis study aimed to develop a computed tomography (CT)-based radiomics model capable of precisely predicting hyperprogression and pseudoprogression (PP) in patients with non-small cell lung cancer (NSCLC) treated with immunotherapy. We retros
Externí odkaz:
https://doaj.org/article/e25ec82eadb64ae59a20c5925f850ab1
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe variability and unpredictability of immune checkpoint inhibitors (ICIs) in treating brain metastases (BMs) in patients with advanced non-small cell lung cancer (NSCLC) is the main concern. We assessed the utility of novel imaging biom
Externí odkaz:
https://doaj.org/article/e8ca9b624af24623a99bfce4d846451a
Publikováno v:
MedComm, Vol 4, Iss 3, Pp n/a-n/a (2023)
Abstract The optimum fractionation of radiation to combine with immune checkpoint blockade is controversial. This study aimed to investigate the fractionated radiation to maximize immunity during combination therapy. To evaluate the abscopal effect,
Externí odkaz:
https://doaj.org/article/0b0892fc7e0e47db93653e37126250c0
Autor:
Huixian Xin, Yuchen Liu, Pengxiang Chen, Tianwen Yin, Meijie Wang, Tianyu Liu, Zhihua Wen, Yufeng Cheng
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-16 (2022)
Abstract The expression of CD155 has been observed to increase in various human cancers, but its role in the development of esophageal cancer (EC) is unclear. Radiotherapy is one of the primary therapeutic options for EC. However, radioresistance is
Externí odkaz:
https://doaj.org/article/bc2c78198ecc4b65970fc48d21d2b4a1
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-12 (2021)
Abstract As a curative treatment of localized tumours or as palliative control, radiotherapy (RT) has long been known to kill tumour cells and trigger the release of proinflammatory factors and immune cells to elicit an immunological response to canc
Externí odkaz:
https://doaj.org/article/42f59f10eabc4c2a9c598b2c71c87aa7
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPre-clinical and clinical evidences support that simultaneous blockade of programmed death-1 (PD-1) and vascular endothelial growth factor receptor (VEGFR) can enhance antigen-specific T-cell migration, and show tolerable toxicity with favo
Externí odkaz:
https://doaj.org/article/17799ffe3660403a86905eb65e9b7002
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:1253-1261
Purpose Growing numbers of clinical trials test the efficacy of radiotherapy (RT) plus immune checkpoint inhibitors (ICIs), but the number of irradiated sites is not uniform. We aimed to evaluate the efficacy of single-site RT plus immunotherapy in o
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-12 (2021)
Biomarker Research
Biomarker Research
As a curative treatment of localized tumours or as palliative control, radiotherapy (RT) has long been known to kill tumour cells and trigger the release of proinflammatory factors and immune cells to elicit an immunological response to cancer. As a
Backgrounds: Local radiation could enhance immune response that mediates tumor regression. Recent studies focus on adding immunotherapy to RT to improve treatment response and induce abscopal response. As a stimulator for granulocytes, the clinical a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42ed8b9f27603e1afc292949d77899e7
https://doi.org/10.21203/rs.3.rs-994384/v1
https://doi.org/10.21203/rs.3.rs-994384/v1